Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem
Adam Blevins, Jennifer Lashinsky, Craig McCammon, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 5
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection
Edward T. Qian, Jonathan D. Casey, Adam Wright, et al.
JAMA (2023) Vol. 330, Iss. 16, pp. 1557-1557
Open Access | Times Cited: 64
Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?
Claire Roger, Benjamin Louart
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1505-1505
Open Access | Times Cited: 85
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review
Matthew Blair, Jean Côté, Aoife G. Cotter, et al.
American Journal of Nephrology (2021) Vol. 52, Iss. 2, pp. 85-97
Open Access | Times Cited: 73
Association of vancomycin plus piperacillin–tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study
Todd A. Miano, Sean Hennessy, Wei Yang, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 9, pp. 1144-1155
Open Access | Times Cited: 67
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis
Ioannis Bellos, Vasilios Karageorgiou, Vasilios Pergialiotis, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 6, pp. 696-705
Open Access | Times Cited: 65
A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients
Alyssa Y. Chen, Chih-Ying Deng, Paola Calvachi, et al.
CHEST Journal (2023) Vol. 164, Iss. 2, pp. 355-368
Open Access | Times Cited: 15
Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis
Abdulmajeed M. Alshehri, Majed S. Al Yami, Atheer Aldairem, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Incidence of Acute Kidney Injury (AKI) in Critically Ill Patients Receiving Concomitant Vancomycin with Piperacillin-Tazobactam or Cefepime; a Systemic Review and Meta-analysis
Lamees Mohamed Alaradi, Nada Albariqi, Mona Alanazi, et al.
Journal of Intensive Care Medicine (2025)
Closed Access
Risk of Acute Kidney Injury andClostridioides difficileInfection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin
Jazmin D Lee, Brett H. Heintz, Hilary J. Mosher, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1579-e1586
Open Access | Times Cited: 24
Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study
Kevin O’Callaghan, Karen Hay, Jayshree Lavana, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 1, pp. 106010-106010
Closed Access | Times Cited: 20
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study
Mitchell S. Buckley, Ivan Komerdelj, Paul A. D’Alessio, et al.
Journal of Critical Care (2021) Vol. 67, pp. 134-140
Closed Access | Times Cited: 17
Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies
Abdulmajeed M. Alshehri, Mohammed Alzahrani, Mohammed Abujamal, et al.
Antibiotics (2022) Vol. 11, Iss. 4, pp. 526-526
Open Access | Times Cited: 12
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam
Sara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e1444-e1455
Closed Access | Times Cited: 12
Association between piperacillin/tazobactam use and acute kidney injury in critically ill patients: a retrospective multicentre cohort study
Bruno Martins Tomazini, Bruno Adler Maccagnan Pinheiro Besen, Leandro Utino Taniguchi, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 3, pp. 552-558
Closed Access | Times Cited: 2
Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
Kelly Maguigan, Mohammad H. Al‐Shaer, Charles A. Peloquin
Antibiotics (2021) Vol. 10, Iss. 10, pp. 1154-1154
Open Access | Times Cited: 16
Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis
Guobin Su, Cuixia Xiao, Yue Cao, et al.
International Journal of Antimicrobial Agents (2022) Vol. 61, Iss. 1, pp. 106691-106691
Closed Access | Times Cited: 11
Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study
Frederico Carlos de Sousa Arnaud, Alexandre Braga Libório
Journal of Antimicrobial Chemotherapy (2019) Vol. 75, Iss. 4, pp. 1031-1037
Closed Access | Times Cited: 16
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry
Sara Alosaimy, Michael J. Rybak, George Sakoulas
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. e179-e188
Closed Access | Times Cited: 5
Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy
Jessica D. Workum, Cornelis Kramers, Eva Kolwijck, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 1, pp. 212-219
Open Access | Times Cited: 13
Vancomycin plus piperacillin/tazobactam and acute kidney injury risk: A review of the literature
Kelly L. Covert, Danielle Knoetze, Miranda Cole, et al.
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 6, pp. 1253-1263
Open Access | Times Cited: 12
Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial
Edward T. Qian, Li Wang, Joanna L. Stollings, et al.
Journal of Intensive Care Medicine (2023) Vol. 38, Iss. 12, pp. 1127-1135
Open Access | Times Cited: 4
Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity
R. F. Tookhi, N. A. Kabli, M. A. Huntul, et al.
Internal and Emergency Medicine (2021) Vol. 16, Iss. 4, pp. 975-979
Closed Access | Times Cited: 10
Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial
Hossein Khalili, Hamid Rahmani, Mostafa Mohammadi, et al.
DARU Journal of Pharmaceutical Sciences (2021) Vol. 29, Iss. 2, pp. 341-351
Open Access | Times Cited: 10
Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients
Jean Côté, Michaël Desjardins, Jean‐François Cailhier, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264281-e0264281
Open Access | Times Cited: 7
Epidemiology of Vancomycin in Combination With Piperacillin/Tazobactam-Associated Acute Kidney Injury in Children: A Systematic Review and Meta-analysis
Miao Zhang, Liang Huang, Yu Zhu, et al.
Annals of Pharmacotherapy (2024) Vol. 58, Iss. 10, pp. 1034-1044
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top